Retour

What 8 Analyst Ratings Have To Say About Inari Medical

Analyst Analyst Ratings

8 analysts have expressed a variety of opinions on Inari Medical (NASDAQ:NARI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 0 3 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 1 0 0 2M Ago 3 0 2 0 0 3M Ago 1 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $66.75, along with a high estimate of $75.00 and a low estimate of $52.00. This current average has decreased by 8.06% from the previous average price target of $72.60. Investigating Analyst Ratings: An Elaborate Study The perception of Inari Medical by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target William Plovanic Canaccord Genuity Maintains Buy $75.00 $75.00 Richard Newitter Truist Securities Lowers Hold $52.00 $61.00 Mike Matson Needham Maintains Buy $72.00 - Mike Matson Needham Maintains Buy $72.00 - Richard Newitter Truist Securities Lowers Hold $61.00 $63.00 Adam Maeder Piper Sandler Lowers Neutral $55.00 $85.00 William Plovanic Canaccord Genuity Lowers Buy $75.00 $79.00 Mike Matson Needham Announces Buy $72.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Inari Medical. This information provides ...Full story available on Benzinga.com

Benzinga • 12/04/2024 à 19:01:40
Inari Medical, Inc. Common Stock
Address: 6001 OAK CANYON, SUITE 100
Postal Code: 92618
City: IRVINE
State: CA
Phone Number: 949-923-4747
Website: https://www.inarimedical.com
Status: Active
Company Info

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

List Date2020-05-22
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001531048
Composite figiBBG009J8K7M0
Share Class figiBBG009J8K7N9
Market Cap2,543,544,456 USD
SIC Code3841
SIC DescriptionSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Total Employees1300
Share Class Shares Outstanding58140000
Weighted Shares Outstanding58138159
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
46.575
45.539
45.49
43.416
42.485
Variance
2.36%
0.26%
4.79%
1.98%
1.6%
Open
45.5
45.419
43.409
42.571
41.815
Highest
47.359
46.814
46.918
43.754
42.863
Lowest
47.21
46.687
46.833
43.74
42.8
History
PeriodVarhighestlowest
1 week
11.38%
42.863
42.8
1 month
13.64%
41.354
38.875
3 month
-20.43%
62.555
38.875
6 month
-20.43%
62.555
38.875
1 year
-20.43%
62.555
38.875
3 year
-20.43%
62.555
38.875
5 year
-20.43%
62.555
38.875
10 year
-20.43%
62.555
38.875
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-01 UNPUB
Assets 506,534,000 524,968,000 548,835,000 UNPUB
Current Assets 425,606,000 444,617,000 469,061,000 UNPUB
Current Liabilities 48,340,000 58,238,000 66,066,000 UNPUB
Equity 426,736,000 435,645,000 452,142,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 426,736,000 435,645,000 452,142,000 UNPUB
Liabilities 79,798,000 89,323,000 96,693,000 UNPUB
Liabilities And Equity 506,534,000 524,968,000 548,835,000 UNPUB
Noncurrent Assets 80,928,000 80,351,000 79,774,000 UNPUB
Noncurrent Liabilities 31,458,000 31,085,000 30,627,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-01 UNPUB
Exchange Gains/Losses -70,000 -53,000 118,000 UNPUB
Net Cash Flow -3,660,000 1,275,000 31,345,000 UNPUB
Net Cash Flow, Continuing -3,590,000 1,328,000 31,227,000 UNPUB
Net Cash Flow From Financing Activities 2,466,000 -2,352,000 3,467,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 2,466,000 -2,352,000 3,467,000 UNPUB
Net Cash Flow From Investing Activities -4,043,000 -6,080,000 11,821,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -4,043,000 -6,080,000 11,821,000 UNPUB
Net Cash Flow From Operating Activities -2,013,000 9,760,000 15,939,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -2,013,000 9,760,000 15,939,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-01 UNPUB
Comprehensive Income/Loss -3,074,000 911,000 3,185,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -3,074,000 911,000 3,185,000 UNPUB
Other Comprehensive Income/Loss -856,000 -1,174,000 23,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent -856,000 -1,174,000 23,000 UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-01 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 117,361,000 115,981,000 120,776,000 UNPUB
Cost Of Revenue 13,741,000 13,844,000 14,477,000 UNPUB
Costs And Expenses 117,361,000 115,981,000 120,776,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 102,426,000 105,161,000 111,889,000 UNPUB
Income/Loss From Continuing Operations After Tax -2,218,000 2,085,000 3,162,000 UNPUB
Income/Loss From Continuing Operations Before Tax -1,194,000 3,024,000 5,590,000 UNPUB
Income Tax Expense/Benefit 1,024,000 939,000 2,428,000 UNPUB
Interest Expense, Operating 40,000 44,000 43,000 UNPUB
Net Income/Loss -2,218,000 2,085,000 3,162,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -2,218,000 2,085,000 3,162,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -2,218,000 2,085,000 3,162,000 UNPUB
Operating Expenses 107,764,000 106,671,000 109,776,000 UNPUB
Operating Income/Loss -5,338,000 -1,510,000 2,113,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 116,167,000 119,005,000 126,366,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-02 2023-02-27
Assets 484,109,000 484,262,000 487,819,000 504,152,000
Current Assets 413,339,000 411,338,000 410,571,000 422,905,000
Current Liabilities 35,580,000 40,984,000 42,343,000 56,174,000
Equity 418,812,000 413,778,000 415,099,000 417,002,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 418,812,000 413,778,000 415,099,000 417,002,000
Liabilities 65,297,000 70,484,000 72,720,000 87,150,000
Liabilities And Equity 484,109,000 484,262,000 487,819,000 504,152,000
Noncurrent Assets 70,770,000 72,924,000 77,248,000 81,247,000
Noncurrent Liabilities 0 0 30,377,000 30,976,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-02 2023-02-27
Exchange Gains/Losses -127,000 -316,000 -412,000 -480,000
Net Cash Flow 93,804,000 -106,832,000 3,804,000 -32,530,000
Net Cash Flow, Continuing 93,931,000 -106,516,000 4,216,000 -32,050,000
Net Cash Flow From Financing Activities 176,542,000 -1,595,000 3,880,000 177,138,000
Net Cash Flow From Financing Activities, Continuing 176,542,000 -1,595,000 3,880,000 177,138,000
Net Cash Flow From Investing Activities -73,511,000 -101,860,000 13,402,000 -195,216,000
Net Cash Flow From Investing Activities, Continuing -73,511,000 -101,860,000 13,402,000 -195,216,000
Net Cash Flow From Operating Activities -9,100,000 -3,061,000 -13,066,000 -13,972,000
Net Cash Flow From Operating Activities, Continuing -9,100,000 -3,061,000 -13,066,000 -13,972,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-02 2023-02-27
Comprehensive Income/Loss -3,494,000 -10,603,000 -9,915,000 -28,016,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,494,000 -10,603,000 -9,915,000 -28,016,000
Other Comprehensive Income/Loss -365,000 -416,000 238,000 1,251,000
Other Comprehensive Income/Loss Attributable To Parent -365,000 -416,000 238,000 1,251,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-02 2023-02-27
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses 89,881,000 101,679,000 105,517,000 409,656,000
Cost Of Revenue 9,967,000 10,347,000 11,064,000 44,506,000
Costs And Expenses 89,881,000 101,679,000 105,517,000 409,656,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit 76,785,000 82,397,000 85,140,000 338,965,000
Income/Loss From Continuing Operations After Tax -3,129,000 -10,187,000 -10,153,000 -29,267,000
Income/Loss From Continuing Operations Before Tax -3,129,000 -8,935,000 -9,313,000 -26,185,000
Income Tax Expense/Benefit 0 1,252,000 840,000 3,082,000
Interest Expense, Operating 73,000 73,000 74,000 294,000
Net Income/Loss -3,129,000 -10,187,000 -10,153,000 -29,267,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,129,000 -10,187,000 -10,153,000 -29,267,000
Net Income/Loss Available To Common Stockholders, Basic -3,129,000 -10,187,000 -10,153,000 -29,267,000
Operating Expenses 79,867,000 91,725,000 94,938,000 367,064,000
Operating Income/Loss -3,082,000 -9,328,000 -9,798,000 -28,099,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 86,752,000 92,744,000 96,204,000 383,471,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-10 2021-11-09 2022-02-23
Assets 234,577,000 253,559,000 292,427,000 311,542,000
Current Assets 221,277,000 228,172,000 228,150,000 245,198,000
Current Liabilities 20,615,000 31,582,000 29,510,000 42,513,000
Equity 213,611,000 221,821,000 234,370,000 239,209,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 213,611,000 221,821,000 234,370,000 239,209,000
Liabilities 20,966,000 31,738,000 58,057,000 72,333,000
Liabilities And Equity 234,577,000 253,559,000 292,427,000 311,542,000
Noncurrent Assets 13,300,000 25,387,000 64,277,000 66,344,000
Noncurrent Liabilities 0 0 28,547,000 29,820,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-10 2021-11-09 2022-02-23
Exchange Gains/Losses -183,000 57,000 -140,000 -402,000
Net Cash Flow -11,714,000 -11,581,000 -10,164,000 -21,865,000
Net Cash Flow, Continuing -11,531,000 -11,638,000 -10,024,000 -21,463,000
Net Cash Flow From Financing Activities 2,214,000 -514,000 2,993,000 4,073,000
Net Cash Flow From Financing Activities, Continuing 2,214,000 -514,000 2,993,000 4,073,000
Net Cash Flow From Investing Activities -22,511,000 -18,426,000 -7,428,000 -51,022,000
Net Cash Flow From Investing Activities, Continuing -22,511,000 -18,426,000 -7,428,000 -51,022,000
Net Cash Flow From Operating Activities 8,766,000 7,302,000 -5,589,000 25,486,000
Net Cash Flow From Operating Activities, Continuing 8,766,000 7,302,000 -5,589,000 25,486,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-10 2021-11-09 2022-02-23
Comprehensive Income/Loss 7,307,000 4,119,000 -2,943,000 9,434,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 7,307,000 4,119,000 -2,943,000 9,434,000
Other Comprehensive Income/Loss -162,000 51,000 -139,000 -406,000
Other Comprehensive Income/Loss Attributable To Parent -162,000 51,000 -139,000 -406,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-10 2021-11-09 2022-02-23
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 49,730,000 59,373,000 75,659,000 266,299,000
Cost Of Revenue 4,623,000 4,814,000 7,040,000 24,757,000
Costs And Expenses 49,730,000 59,373,000 75,659,000 266,299,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 52,774,000 58,639,000 65,876,000 252,227,000
Income/Loss From Continuing Operations After Tax 7,469,000 4,068,000 -2,804,000 9,840,000
Income/Loss From Continuing Operations Before Tax 7,667,000 4,080,000 -2,743,000 10,685,000
Income Tax Expense/Benefit 198,000 12,000 61,000 845,000
Interest Expense, Operating 73,000 74,000 73,000 295,000
Net Income/Loss 7,469,000 4,068,000 -2,804,000 9,840,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 7,469,000 4,068,000 -2,804,000 9,840,000
Net Income/Loss Available To Common Stockholders, Basic 7,469,000 4,068,000 -2,804,000 9,840,000
Operating Expenses 45,061,000 54,527,000 68,603,000 241,383,000
Operating Income/Loss 7,713,000 4,112,000 -2,727,000 10,844,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 57,397,000 63,453,000 72,916,000 276,984,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-12 2021-03-09
Assets UNPUB 224,354,000 205,811,000 214,092,000
Current Assets UNPUB 219,764,000 199,461,000 205,673,000
Current Liabilities UNPUB 10,902,000 14,327,000 13,838,000
Equity UNPUB 183,870,000 191,484,000 200,254,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 183,870,000 191,484,000 200,254,000
Liabilities UNPUB 40,484,000 14,327,000 13,838,000
Liabilities And Equity UNPUB 224,354,000 205,811,000 214,092,000
Noncurrent Assets UNPUB 4,590,000 6,350,000 8,419,000
Noncurrent Liabilities UNPUB 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-12 2021-03-09
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB -26,848,000 90,590,000
Net Cash Flow, Continuing UNPUB UNPUB -26,848,000 90,590,000
Net Cash Flow From Financing Activities UNPUB UNPUB -30,531,000 144,115,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB -30,531,000 144,115,000
Net Cash Flow From Investing Activities UNPUB UNPUB -1,658,000 -55,437,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -1,658,000 -55,437,000
Net Cash Flow From Operating Activities UNPUB UNPUB 5,341,000 1,912,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB 5,341,000 1,912,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-12 2021-03-09
Comprehensive Income/Loss UNPUB -3,804,000 6,496,000 13,793,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -3,804,000 6,496,000 13,793,000
Other Comprehensive Income/Loss UNPUB 0 0 4,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-12 2021-03-09
Basic Earnings Per Share UNPUB 0 0 0
Benefits Costs and Expenses UNPUB 29,196,000 32,219,000 125,881,000
Cost Of Revenue UNPUB 3,487,000 3,228,000 13,106,000
Costs And Expenses UNPUB 29,196,000 32,219,000 125,881,000
Diluted Earnings Per Share UNPUB 0 0 0
Gross Profit UNPUB 21,905,000 35,487,000 126,564,000
Income/Loss From Continuing Operations After Tax UNPUB -3,804,000 6,496,000 13,789,000
Income/Loss From Continuing Operations Before Tax UNPUB -3,804,000 6,496,000 13,789,000
Income Tax Expense/Benefit UNPUB 0 0 0
Interest Expense, Operating UNPUB 463,000 251,000 1,135,000
Net Income/Loss UNPUB -3,804,000 6,496,000 13,789,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -3,804,000 6,496,000 13,789,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -3,804,000 6,496,000 13,789,000
Operating Expenses UNPUB 22,508,000 28,297,000 108,145,000
Operating Income/Loss UNPUB -603,000 7,190,000 18,419,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 25,392,000 38,715,000 139,670,000
Calendar
16 May 2024 (Time UTC) Actual Previous Consensus
★
08:30
United States
MAY 10
215000.000
★★
08:30
United States
MAY 10
231000.000
220000.000
★★
08:30
United States
APR
0.400
0.400
★
08:30
United States
APR
0.400
★
08:30
United States
APR
1321000.000
1410000.000
★★
08:30
United States
APR
-14.700
★
08:30
United States
APR
-1.400
★
08:30
United States
MAY 10
1785000.000
1780000.000
★★
08:30
United States
MAY
-10.700
★
08:30
United States
MAY
20.000
★
08:30
United States
MAY
12.200
★
08:30
United States
MAY
34.300
★
08:30
United States
MAY
23.000
★★★
08:30
United States
MAY
15.500
7.700
★★
08:30
United States
MAY
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:NARI240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:NARI240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:NARI240419P00085000 OPASPS Put American 100 85 BATO 2024-04-19
O:NARI240419P00080000 OPASPS Put American 100 80 BATO 2024-04-19
O:NARI240419P00075000 OPASPS Put American 100 75 BATO 2024-04-19
O:NARI240419P00070000 OPASPS Put American 100 70 BATO 2024-04-19
O:NARI240419P00065000 OPASPS Put American 100 65 BATO 2024-04-19
O:NARI240419P00060000 OPASPS Put American 100 60 BATO 2024-04-19
O:NARI240419P00055000 OPASPS Put American 100 55 BATO 2024-04-19
O:NARI240419P00050000 OPASPS Put American 100 50 BATO 2024-04-19
O:NARI240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:NARI240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:NARI240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:NARI240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:NARI240419C00085000 OCASPS Call American 100 85 BATO 2024-04-19
O:NARI240419C00080000 OCASPS Call American 100 80 BATO 2024-04-19
O:NARI240419C00075000 OCASPS Call American 100 75 BATO 2024-04-19
O:NARI240419C00070000 OCASPS Call American 100 70 BATO 2024-04-19
O:NARI240419C00065000 OCASPS Call American 100 65 BATO 2024-04-19
O:NARI240419C00060000 OCASPS Call American 100 60 BATO 2024-04-19
O:NARI240419C00055000 OCASPS Call American 100 55 BATO 2024-04-19
O:NARI240419C00050000 OCASPS Call American 100 50 BATO 2024-04-19
O:NARI240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:NARI240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:NARI240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:NARI240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:NARI240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:NARI240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:NARI240315P00085000 OPASPS Put American 100 85 BATO 2024-03-15
O:NARI240315P00080000 OPASPS Put American 100 80 BATO 2024-03-15
O:NARI240315P00075000 OPASPS Put American 100 75 BATO 2024-03-15
O:NARI240315P00070000 OPASPS Put American 100 70 BATO 2024-03-15
O:NARI240315P00065000 OPASPS Put American 100 65 BATO 2024-03-15
O:NARI240315P00060000 OPASPS Put American 100 60 BATO 2024-03-15
O:NARI240315P00055000 OPASPS Put American 100 55 BATO 2024-03-15
O:NARI240315P00050000 OPASPS Put American 100 50 BATO 2024-03-15
O:NARI240315P00045000 OPASPS Put American 100 45 BATO 2024-03-15
O:NARI240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:NARI240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:NARI240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:NARI240315C00085000 OCASPS Call American 100 85 BATO 2024-03-15
O:NARI240315C00080000 OCASPS Call American 100 80 BATO 2024-03-15
O:NARI240315C00075000 OCASPS Call American 100 75 BATO 2024-03-15
O:NARI240315C00070000 OCASPS Call American 100 70 BATO 2024-03-15
O:NARI240315C00065000 OCASPS Call American 100 65 BATO 2024-03-15
O:NARI240315C00060000 OCASPS Call American 100 60 BATO 2024-03-15
O:NARI240315C00055000 OCASPS Call American 100 55 BATO 2024-03-15
O:NARI240315C00050000 OCASPS Call American 100 50 BATO 2024-03-15
O:NARI240315C00045000 OCASPS Call American 100 45 BATO 2024-03-15
O:NARI240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:NARI240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:NARI240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:NARI240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:NARI240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:NARI240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:NARI240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:NARI240216P00090000 OPASPS Put American 100 90 BATO 2024-02-16
O:NARI240216P00085000 OPASPS Put American 100 85 BATO 2024-02-16
O:NARI240216P00080000 OPASPS Put American 100 80 BATO 2024-02-16
O:NARI240216P00075000 OPASPS Put American 100 75 BATO 2024-02-16
O:NARI240216P00070000 OPASPS Put American 100 70 BATO 2024-02-16
O:NARI240216P00065000 OPASPS Put American 100 65 BATO 2024-02-16
O:NARI240216P00060000 OPASPS Put American 100 60 BATO 2024-02-16
O:NARI240216P00055000 OPASPS Put American 100 55 BATO 2024-02-16
O:NARI240216P00050000 OPASPS Put American 100 50 BATO 2024-02-16
O:NARI240216P00045000 OPASPS Put American 100 45 BATO 2024-02-16
O:NARI240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:NARI240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:NARI240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:NARI240216C00090000 OCASPS Call American 100 90 BATO 2024-02-16
O:NARI240216C00085000 OCASPS Call American 100 85 BATO 2024-02-16
O:NARI240216C00080000 OCASPS Call American 100 80 BATO 2024-02-16
O:NARI240216C00075000 OCASPS Call American 100 75 BATO 2024-02-16
O:NARI240216C00070000 OCASPS Call American 100 70 BATO 2024-02-16
O:NARI240216C00065000 OCASPS Call American 100 65 BATO 2024-02-16
O:NARI240216C00060000 OCASPS Call American 100 60 BATO 2024-02-16
O:NARI240216C00055000 OCASPS Call American 100 55 BATO 2024-02-16
O:NARI240216C00050000 OCASPS Call American 100 50 BATO 2024-02-16
O:NARI240216C00045000 OCASPS Call American 100 45 BATO 2024-02-16
O:NARI240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:NARI240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:NARI240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:NARI240216P00095000 OPASPS Put American 100 95 BATO 2024-02-16
O:NARI240216C00095000 OCASPS Call American 100 95 BATO 2024-02-16
O:NARI240216P00100000 OPASPS Put American 100 100 BATO 2024-02-16
O:NARI240216C00100000 OCASPS Call American 100 100 BATO 2024-02-16
O:NARI240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:NARI240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:NARI240119P00105000 OPASPS Put American 100 105 BATO 2024-01-19
O:NARI240119P00100000 OPASPS Put American 100 100 BATO 2024-01-19
O:NARI240119P00095000 OPASPS Put American 100 95 BATO 2024-01-19
O:NARI240119P00090000 OPASPS Put American 100 90 BATO 2024-01-19
O:NARI240119P00085000 OPASPS Put American 100 85 BATO 2024-01-19
O:NARI240119P00080000 OPASPS Put American 100 80 BATO 2024-01-19
O:NARI240119P00075000 OPASPS Put American 100 75 BATO 2024-01-19
O:NARI240119P00070000 OPASPS Put American 100 70 BATO 2024-01-19
O:NARI240119P00065000 OPASPS Put American 100 65 BATO 2024-01-19
O:NARI240119P00060000 OPASPS Put American 100 60 BATO 2024-01-19
O:NARI240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:NARI240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:NARI240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:NARI240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:NARI240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:NARI240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:NARI240119C00105000 OCASPS Call American 100 105 BATO 2024-01-19
O:NARI240119C00100000 OCASPS Call American 100 100 BATO 2024-01-19
O:NARI240119C00095000 OCASPS Call American 100 95 BATO 2024-01-19
O:NARI240119C00090000 OCASPS Call American 100 90 BATO 2024-01-19
O:NARI240119C00085000 OCASPS Call American 100 85 BATO 2024-01-19
O:NARI240119C00080000 OCASPS Call American 100 80 BATO 2024-01-19
O:NARI240119C00075000 OCASPS Call American 100 75 BATO 2024-01-19
O:NARI240119C00070000 OCASPS Call American 100 70 BATO 2024-01-19
O:NARI240119C00065000 OCASPS Call American 100 65 BATO 2024-01-19
O:NARI240119C00060000 OCASPS Call American 100 60 BATO 2024-01-19
O:NARI240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:NARI240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:NARI240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:NARI240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:NARI240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:NARI240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:NARI231215P00070000 OPASPS Put American 100 70 BATO 2023-12-15
O:NARI231215P00065000 OPASPS Put American 100 65 BATO 2023-12-15
O:NARI231215P00060000 OPASPS Put American 100 60 BATO 2023-12-15
O:NARI231215P00055000 OPASPS Put American 100 55 BATO 2023-12-15
O:NARI231215P00050000 OPASPS Put American 100 50 BATO 2023-12-15
O:NARI231215P00045000 OPASPS Put American 100 45 BATO 2023-12-15
O:NARI231215P00040000 OPASPS Put American 100 40 BATO 2023-12-15
O:NARI231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:NARI231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:NARI231215C00085000 OCASPS Call American 100 85 BATO 2023-12-15
O:NARI231215C00080000 OCASPS Call American 100 80 BATO 2023-12-15
O:NARI231215C00075000 OCASPS Call American 100 75 BATO 2023-12-15
O:NARI231215C00070000 OCASPS Call American 100 70 BATO 2023-12-15
O:NARI231215C00065000 OCASPS Call American 100 65 BATO 2023-12-15
O:NARI231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:NARI231215C00060000 OCASPS Call American 100 60 BATO 2023-12-15
O:NARI231215C00055000 OCASPS Call American 100 55 BATO 2023-12-15
O:NARI231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:NARI231215C00050000 OCASPS Call American 100 50 BATO 2023-12-15
O:NARI231215C00045000 OCASPS Call American 100 45 BATO 2023-12-15
O:NARI231215C00040000 OCASPS Call American 100 40 BATO 2023-12-15
O:NARI231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:NARI231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:NARI231215P00085000 OPASPS Put American 100 85 BATO 2023-12-15
O:NARI231215P00080000 OPASPS Put American 100 80 BATO 2023-12-15
O:NARI231215P00075000 OPASPS Put American 100 75 BATO 2023-12-15
O:NARI231117P00105000 OPASPS Put American 100 105 BATO 2023-11-17
O:NARI231117P00100000 OPASPS Put American 100 100 BATO 2023-11-17
O:NARI231117P00095000 OPASPS Put American 100 95 BATO 2023-11-17
O:NARI231117P00090000 OPASPS Put American 100 90 BATO 2023-11-17
O:NARI231117P00085000 OPASPS Put American 100 85 BATO 2023-11-17
O:NARI231117P00080000 OPASPS Put American 100 80 BATO 2023-11-17
O:NARI231117P00075000 OPASPS Put American 100 75 BATO 2023-11-17
O:NARI231117P00070000 OPASPS Put American 100 70 BATO 2023-11-17
O:NARI231117P00065000 OPASPS Put American 100 65 BATO 2023-11-17
O:NARI231117P00060000 OPASPS Put American 100 60 BATO 2023-11-17
O:NARI231117P00055000 OPASPS Put American 100 55 BATO 2023-11-17
O:NARI231117P00050000 OPASPS Put American 100 50 BATO 2023-11-17
O:NARI231117P00045000 OPASPS Put American 100 45 BATO 2023-11-17
O:NARI231117P00040000 OPASPS Put American 100 40 BATO 2023-11-17
O:NARI231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:NARI231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:NARI231117C00105000 OCASPS Call American 100 105 BATO 2023-11-17
O:NARI231117C00100000 OCASPS Call American 100 100 BATO 2023-11-17
O:NARI231117C00095000 OCASPS Call American 100 95 BATO 2023-11-17
O:NARI231117C00090000 OCASPS Call American 100 90 BATO 2023-11-17
O:NARI231117C00085000 OCASPS Call American 100 85 BATO 2023-11-17
O:NARI231117C00080000 OCASPS Call American 100 80 BATO 2023-11-17
O:NARI231117C00075000 OCASPS Call American 100 75 BATO 2023-11-17
O:NARI231117C00070000 OCASPS Call American 100 70 BATO 2023-11-17
O:NARI231117C00065000 OCASPS Call American 100 65 BATO 2023-11-17
O:NARI231117C00060000 OCASPS Call American 100 60 BATO 2023-11-17
O:NARI231117C00055000 OCASPS Call American 100 55 BATO 2023-11-17
O:NARI231117C00050000 OCASPS Call American 100 50 BATO 2023-11-17
O:NARI231117C00045000 OCASPS Call American 100 45 BATO 2023-11-17
O:NARI231117C00040000 OCASPS Call American 100 40 BATO 2023-11-17
O:NARI231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:NARI231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:NARI231020P00105000 OPASPS Put American 100 105 BATO 2023-10-20
O:NARI231020P00100000 OPASPS Put American 100 100 BATO 2023-10-20
O:NARI231020P00095000 OPASPS Put American 100 95 BATO 2023-10-20
O:NARI231020P00090000 OPASPS Put American 100 90 BATO 2023-10-20
O:NARI231020P00085000 OPASPS Put American 100 85 BATO 2023-10-20
O:NARI231020P00080000 OPASPS Put American 100 80 BATO 2023-10-20
O:NARI231020P00075000 OPASPS Put American 100 75 BATO 2023-10-20
O:NARI231020P00070000 OPASPS Put American 100 70 BATO 2023-10-20
O:NARI231020P00065000 OPASPS Put American 100 65 BATO 2023-10-20
O:NARI231020P00060000 OPASPS Put American 100 60 BATO 2023-10-20
O:NARI231020P00055000 OPASPS Put American 100 55 BATO 2023-10-20
O:NARI231020P00050000 OPASPS Put American 100 50 BATO 2023-10-20
O:NARI231020P00045000 OPASPS Put American 100 45 BATO 2023-10-20
O:NARI231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:NARI231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:NARI231020C00105000 OCASPS Call American 100 105 BATO 2023-10-20
O:NARI231020C00100000 OCASPS Call American 100 100 BATO 2023-10-20
O:NARI231020C00095000 OCASPS Call American 100 95 BATO 2023-10-20
O:NARI231020C00090000 OCASPS Call American 100 90 BATO 2023-10-20
O:NARI231020C00085000 OCASPS Call American 100 85 BATO 2023-10-20
O:NARI231020C00080000 OCASPS Call American 100 80 BATO 2023-10-20
O:NARI231020C00075000 OCASPS Call American 100 75 BATO 2023-10-20
O:NARI231020C00070000 OCASPS Call American 100 70 BATO 2023-10-20
O:NARI231020C00065000 OCASPS Call American 100 65 BATO 2023-10-20
O:NARI231020C00060000 OCASPS Call American 100 60 BATO 2023-10-20
O:NARI231020C00055000 OCASPS Call American 100 55 BATO 2023-10-20
O:NARI231020C00050000 OCASPS Call American 100 50 BATO 2023-10-20
O:NARI231020C00045000 OCASPS Call American 100 45 BATO 2023-10-20
O:NARI231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:NARI231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:NARI231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:NARI231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:NARI230915P00100000 OPASPS Put American 100 100 BATO 2023-09-15
O:NARI230915P00095000 OPASPS Put American 100 95 BATO 2023-09-15
O:NARI230915C00100000 OCASPS Call American 100 100 BATO 2023-09-15
O:NARI230915C00095000 OCASPS Call American 100 95 BATO 2023-09-15
O:NARI230915P00090000 OPASPS Put American 100 90 BATO 2023-09-15
O:NARI230915P00085000 OPASPS Put American 100 85 BATO 2023-09-15
O:NARI230915P00080000 OPASPS Put American 100 80 BATO 2023-09-15
O:NARI230915P00075000 OPASPS Put American 100 75 BATO 2023-09-15
O:NARI230915P00070000 OPASPS Put American 100 70 BATO 2023-09-15
O:NARI230915P00065000 OPASPS Put American 100 65 BATO 2023-09-15
O:NARI230915P00060000 OPASPS Put American 100 60 BATO 2023-09-15
O:NARI230915P00055000 OPASPS Put American 100 55 BATO 2023-09-15
O:NARI230915P00050000 OPASPS Put American 100 50 BATO 2023-09-15
O:NARI230915P00045000 OPASPS Put American 100 45 BATO 2023-09-15
O:NARI230915P00040000 OPASPS Put American 100 40 BATO 2023-09-15
O:NARI230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:NARI230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:NARI230915C00090000 OCASPS Call American 100 90 BATO 2023-09-15
O:NARI230915C00085000 OCASPS Call American 100 85 BATO 2023-09-15
O:NARI230915C00080000 OCASPS Call American 100 80 BATO 2023-09-15
O:NARI230915C00075000 OCASPS Call American 100 75 BATO 2023-09-15
O:NARI230915C00070000 OCASPS Call American 100 70 BATO 2023-09-15
O:NARI230915C00065000 OCASPS Call American 100 65 BATO 2023-09-15
O:NARI230915C00060000 OCASPS Call American 100 60 BATO 2023-09-15
O:NARI230915C00055000 OCASPS Call American 100 55 BATO 2023-09-15
O:NARI230915C00050000 OCASPS Call American 100 50 BATO 2023-09-15
O:NARI230915C00045000 OCASPS Call American 100 45 BATO 2023-09-15
O:NARI230915C00040000 OCASPS Call American 100 40 BATO 2023-09-15
O:NARI230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:NARI230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:NARI230818C00100000 OCASPS Call American 100 100 BATO 2023-08-18
O:NARI230818C00095000 OCASPS Call American 100 95 BATO 2023-08-18
O:NARI230818C00090000 OCASPS Call American 100 90 BATO 2023-08-18
O:NARI230818C00085000 OCASPS Call American 100 85 BATO 2023-08-18
O:NARI230818C00080000 OCASPS Call American 100 80 BATO 2023-08-18
O:NARI230818C00075000 OCASPS Call American 100 75 BATO 2023-08-18
O:NARI230818C00070000 OCASPS Call American 100 70 BATO 2023-08-18
O:NARI230818C00065000 OCASPS Call American 100 65 BATO 2023-08-18
O:NARI230818C00060000 OCASPS Call American 100 60 BATO 2023-08-18
O:NARI230818C00055000 OCASPS Call American 100 55 BATO 2023-08-18
O:NARI230818C00050000 OCASPS Call American 100 50 BATO 2023-08-18
O:NARI230818C00045000 OCASPS Call American 100 45 BATO 2023-08-18
O:NARI230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:NARI230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:NARI230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:NARI230818P00105000 OPASPS Put American 100 105 BATO 2023-08-18
O:NARI230818P00100000 OPASPS Put American 100 100 BATO 2023-08-18
O:NARI230818P00095000 OPASPS Put American 100 95 BATO 2023-08-18
O:NARI230818P00090000 OPASPS Put American 100 90 BATO 2023-08-18
O:NARI230818P00085000 OPASPS Put American 100 85 BATO 2023-08-18
O:NARI230818P00080000 OPASPS Put American 100 80 BATO 2023-08-18
O:NARI230818P00075000 OPASPS Put American 100 75 BATO 2023-08-18
O:NARI230818P00070000 OPASPS Put American 100 70 BATO 2023-08-18
O:NARI230818P00065000 OPASPS Put American 100 65 BATO 2023-08-18
O:NARI230818P00060000 OPASPS Put American 100 60 BATO 2023-08-18
O:NARI230818P00055000 OPASPS Put American 100 55 BATO 2023-08-18
O:NARI230818P00050000 OPASPS Put American 100 50 BATO 2023-08-18
O:NARI230818P00045000 OPASPS Put American 100 45 BATO 2023-08-18
O:NARI230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:NARI230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:NARI230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:NARI230818C00105000 OCASPS Call American 100 105 BATO 2023-08-18
News Stream
Calendar Calendar of Events
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024, at 11:20 AM Pacific Time.
GlobeNewswire Inc. • 1w ago
Stocks Earnings Releases and Operating Results
Inari Medical Reports First Quarter 2024 Financial Results
IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2024.
GlobeNewswire Inc. • 2w ago
Calendar Calendar of Events
Inari Medical to Announce First Quarter 2024 Financial Results
IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
GlobeNewswire Inc. • 4w ago
Analyst Analyst Ratings
What 8 Analyst Ratings Have To Say About Inari Medical
8 analysts have expressed a variety of opinions on Inari Medical (NASDAQ:NARI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 0 3 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 1 0 0 2M Ago 3 0 2 0 0 3M Ago 1 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $66.75, along with a high estimate of $75.00 and a low estimate of $52.00. This current average has decreased by 8.06% from the previous average price target of $72.60. Investigating Analyst Ratings: An Elaborate Study The perception of Inari Medical by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target William Plovanic Canaccord Genuity Maintains Buy $75.00 $75.00 Richard Newitter Truist Securities Lowers Hold $52.00 $61.00 Mike Matson Needham Maintains Buy $72.00 - Mike Matson Needham Maintains Buy $72.00 - Richard Newitter Truist Securities Lowers Hold $61.00 $63.00 Adam Maeder Piper Sandler Lowers Neutral $55.00 $85.00 William Plovanic Canaccord Genuity Lowers Buy $75.00 $79.00 Mike Matson Needham Announces Buy $72.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Inari Medical. This information provides ...Full story available on Benzinga.com
Benzinga • 1mo ago
Stocks Annual report
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Sustainability Report. The report highlights Inari’s commitment to its ethos and important corresponding environmental, social and governance (ESG) initiatives. The report can be found on Inari’s website here.
GlobeNewswire Inc. • 1mo ago
Management Management Changes
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner will be responsible for developing effective strategies across the company's multi-product sales platform and leading a high-performance commercial team to drive therapy penetration. Dr. Niekamp will be instrumental in advancing Inari’s mission to improve patient care through physician education and new device development.
GlobeNewswire Inc. • 1mo ago
News News
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
Inari Medical (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research • 1mo ago
Analyst Analyst Ratings
Forecasting The Future: 7 Analyst Projections For Inari Medical
Across the recent three months, 7 analysts have shared their insights on Inari Medical (NASDAQ:NARI), expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 3 0 0 Last 30D 0 0 1 0 0 1M Ago 3 0 2 0 0 2M Ago 1 0 0 0 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $65.57, along with a high estimate of $75.00 and a low estimate of $52.00. Highlighting a 8.93% decrease, the current average has fallen from the previous average price target of $72.00. Analyzing Analyst Ratings: A Detailed Breakdown An in-depth analysis of recent analyst actions unveils how financial experts perceive Inari Medical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Richard Newitter Truist Securities Lowers Hold $52.00 $61.00 Mike Matson Needham Maintains Buy $72.00 - Mike Matson Needham Maintains Buy $72.00 - Richard Newitter Truist Securities Lowers Hold $61.00 $63.00 Adam Maeder Piper Sandler Lowers Neutral $55.00 $85.00 William Plovanic Canaccord Genuity Lowers Buy $75.00 $79.00 Mike Matson Needham Announces Buy $72.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ...Full story available on Benzinga.com
Benzinga • 1mo ago
News Clinical Study
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials
GlobeNewswire Inc. • 2mo ago
Analyst Analyst Ratings
Critical Insights From Inari Medical Analyst Ratings: What You Need To Know
6 analysts have expressed a variety of opinions on Inari Medical (NASDAQ:NARI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 0 3 0 0 Last 30D 2 0 2 0 0 1M Ago 0 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 0 1 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $67.5, a high estimate of $75.00, and a low estimate of $55.00. Highlighting a 7.53% decrease, the current average has fallen from the previous average price target of $73.00. Investigating Analyst Ratings: An Elaborate Study The analysis of recent analyst actions sheds light on the perception of Inari Medical by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Mike Matson Needham Maintains Buy $72.00 - Richard Newitter Truist Securities Lowers Hold $61.00 $63.00 Adam Maeder Piper Sandler Lowers Neutral $55.00 $85.00 William Plovanic Canaccord Genuity Lowers Buy $75.00 $79.00 Mike Matson Needham Announces Buy $72.00 - Richard Newitter Truist Securities Raises Hold $70.00 $65.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Inari Medical. This information offers ...Full story available on Benzinga.com
Benzinga • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT